Newsletter | Intellectual Property 17/04/2026

After a lengthy negotiation process, on 3 December 2025 the institutions of the European Union reached an agreement on the regulation of New Genomic Techniques, resolving a decade-long political stalemate and reshaping the regulatory framework of the sector.
In the latest newsletter, Chiomenti's Professionals analysed this reform, which overcomes the limitations of the previous GMO regime by introducing a dedicated regulatory framework. The result is a deep revision for the Life Sciences sector: industry players are required to rethink the management of their intangible assets, in a context where the new balance between biotechnology patents and variety patents provides greater stability for the circulation of intellectual property rights.